MedTrace Logo

Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients

NCT02335593 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2020-01-22

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effect of Zinc supplementation on health status of hemodialysis patients through measurement of the following before and after Zinc administration: Inflammatory markers, Oxidative stress markers and Anemia markers. Also, Evaluation of quality of life of hemodialysis patients before and after Zinc administration using Fatigue severity scale questionnaire.

Conditions

Interventions

DIETARY_SUPPLEMENT

Zinc Sulphate

Zinc Sulphate Hard Gel capsules 110mg

OTHER

Corn Starch filled Hard Gel Capsules

Corn Starch filled Hard Gel Capsules

DRUG

Epoetin alfa 2000-4000 IU solution for injection

Epoetin alfa 2000-4000 IU solution for injection

DRUG

Iron Hydroxide Saccharate Complex Solution for injection

Iron Hydroxide Saccharate Complex Solution for injection

Sponsors & Collaborators

  • National Institute of Urology and Nephrology

    collaborator UNKNOWN

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Rasha R. El-kady, Bachelor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335593 on ClinicalTrials.gov